☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
MACE Reduction
Janssen Pharmaceuticals (J&J) Receives Health Canada's Approval for Invokana (canagliflozin) in MACE Reduction
October 18, 2018
Load more...
Back to Home